Stay updated with breaking news from Evidence Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On November 12, 2021, the Centers for Medicare and Medicaid Services (CMS) issued a final rule rescinding the Medicare Coverage of Innovative Technology and Definition of “Reasonable...
On November 15, 2021, the Centers for Medicare and Medicaid Services ("CMS") issued a final rule1 implementing, without substantial modification, its September proposed rule2...
Alice K. Jacobs was awarded the James B. Herrick Award for Outstanding Achievement in Clinical Cardiology by the American Heart Association.
An analysis of a Medicare administrative database finds about 30% lower mortality associated with sleeve gastrectomy.
Alzheimer's Association Welcomes CMS Announcement of National Coverage Determination Analysis on Treatment for Alzheimer's Disease News provided by Share this article Share this article CHICAGO, July 12, 2021 /PRNewswire/ -- On behalf of all those living with Alzheimer's disease, their caregivers, and their families, we appreciate the Centers for Medicare & Medicaid Services (CMS) thoughtful consideration on coverage considerations for monoclonal antibodies targeting amyloid for the treatment of Alzheimer's disease, including aducanumab, which was recently approved by the Food and Drug Admini...